- Device
- SELUTION SLR™ 014 PTCA Drug-Eluting Balloon
- Applicant
- MedAlliance, LLC
- PMA number
- P250041
- Supplement
- S001
- Product code
- OOB
- Generic name
- Drug-eluting percutaneous transluminal coronary angioplasty catheter
- Decision date
- 2026-11-06
- Decision code
- APPR
- Date received
- 2026-10-08
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol
- Approval order statement
- SELUTION4ISR Continued Follow-up Study will evaluate the long-term safety and effectiveness of the SELUTION SLR PTCA DEB in 418 subjects from the premarket study (SELUTION4ISR). Subjects will be followed annually through 5 years post-procedure, and all efforts will be made to minimize the amount of missing long-term data.